Back to Results
First PageMeta Content
Pharmacoeconomics / Health services research / Erasmus University Rotterdam / Medical technology assessment / Cost–utility analysis / Chronic obstructive pulmonary disease / Cost-effectiveness analysis / Health technology assessment / Health policy / Health economics / Health / Medicine


Document Date: 2009-10-22 04:32:12

Open Document

File Size: 366,46 KB

Share Result on Facebook

City

Utrecht / Barcelona / Budapest / Rotterdam / Paris / The Hague / Prague / Amsterdam / Vienna / Bair / Brussels / /

Company

iMTA Nepal / iMTA / /

Country

Hungary / Netherlands / Spain / /

/

Event

Person Travel / Environmental Issue / /

Facility

Institute of Public Health / University Hospital Maastricht / Dutch College / University of Alicante / University of Amsterdam / University of Maastricht / University Pompeu Fabra / Erasmus University / Maxima Medical Center / Hoboken complex / /

IndustryTerm

pharmaceutical industry / cancer therapy / large pharmaceutical / health care technologies / health technology assessment / record healthcare utilization / important tool / health technologies / technology assessment / policy tool / healthcare interventions / pharmaceutical policy / insurance package / /

MedicalCondition

COPD / multiple myeloma / dynamic population-based COPD / breast cancer / asthma / larynx tumours / physician-diagnosed COPD / Cancer / disease / musculoskeletal diseases / pulmonary function / rheumatic diseases / diabetes / home-based multidisciplinary COPD / chronic lung diseases / chronic lung disease / cancer therapy lung state / /

MedicalTreatment

counseling / physiotherapy / cancer therapy / pharmacotherapy / in vitro fertilization / /

NaturalFeature

MT Groot / /

Organization

University Hospital Maastricht and Maxima Medical Center / Dutch College for Health Care Insurance / World Health Organization / Institute for Public Health and the Environment / University of Alicante / Dutch Society of Technology Assessment / QALY league / Erasmus MC / Institute for Medical Technology Assessment / OECD / Congress / Foundation for Asthma Treatment / University of Maastricht / Dutch Society of Tropical Medicine and International Health / Institute of Public Health / Dutch Asthma Foundation / Decision Analysis Society / University of Amsterdam / Department of Health Economics / Erasmus University / Health Insurance Board / Union against Tuberculosis and Lung Disease / National Health Insurance Fund Administration / Department of Health Economic / International Society of Quality of Life Research / /

Person

Talitha Feenstra / Maureen Rutten / Frans Rutten / Jose Luis Pinto / Paul van der Maas / Carin Uyl / Jan Oostenbrink / Carmen Herrero / Martine Hoogendoorn-Lips / Werner Brouwer / Ben van Hout / Paul J. van der Maas / Michel van Agthoven / Gouke Bonsel / Peter Wakker / Ineke de Klerk / /

/

Position

first director / Minister of Health / secretary / faculty chair / dean and vice president / Chairman of the department / senior researcher / respiratory nurse / Professor / director / chair to Frans Rutten / lecturer / founder / /

Product

Acetylcysteine / simvastatin / /

PublishedMedium

Health Economics / /

Technology

expensive health care technologies / transplantation / health technologies / /

URL

www.imta.nl / www.imta.nl/lustrum.html / /

SocialTag